Analysts await Constellium N.V. (NASDAQ:CSTM) to report earnings on Mar, 15 for the fiscal quarter ending Dec 2015.

They expect $0.07 EPS, down 428.57% or $0.3 from last year’s $0.37 per share.

At the moment 12 analysts are watching Constellium N.V. (NASDAQ:CSTM), 2 rate it “Buy”, 6 “Outperform”, 4 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 4 analysts have a mean sales target of 1,348.63 million. For the quarter ending Jun-16, 4 analysts have a mean sales target of 1,419.12 million whilst for the year ending Dec-16, 10 analysts have a mean target of 5,790.45 million.

In terms of earnings per share, 7 analysts have a 0.21 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 7 analysts have a 0.26 EPS mean target and for the quarter ending Jun-16 there are 10 estimates of 0.86 EPS.

The biggest institutional shareholders in Constellium N.V. include Adage Capital Partners Gp LLC which owns 10 million shares in the company valued at $79.73 million. North Run Capital, L P is the second biggest holder with 8 million shares currently valued at 62.56 million whilst Vaughan Nelson Scarbrgh & Mccullough LP has 7 million shares valued at 53.64 million.

Total shares held by institutions as of the most recent company filings are 89,153,474 with a reported 9,796,494 bought and 9,677,026 sold. These holdings make up 66.82% of the company’s outstanding shares.

The stock decreased 0.15% or $0.01 during the last trading session, hitting $12.00. Constellium N.V. (NASDAQ:CSTM) has risen 33.83% over the past 6 months and is uptrending.